A 40-year-old, HIV and hepatitisC virus co-infected woman was treated with interferon and ribavirine and developed a TTP confirmed by the presence of anti-ADAMTS13 antibodies. The outcome was favourable when treatment was discontinued and rituximab infusion administered. The occurrence of anemia ...